COSTANZO, Antonio et al. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study. Acta Dermato-Venereologica, [S. l.], v. 101, n. 10, p. adv00576, 2021. DOI: 10.2340/00015555-3816. Disponível em: https://medicaljournalssweden.se/actadv/article/view/468. Acesso em: 30 may. 2026.